BRCA1 and ovarian carcinoma: After excluding L63X founder mutation, the proportion of patients with a family history of ovarian cancer and germline BRCA1 mutations outside the OCCR was lower and the proportion of patients with a family history of breast cancer and germline BRCA1 mutations within the OCCR was relatively lower [56].